| Product Code: ETC4746633 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The Angola Influenza Vaccine Market is likely to experience consistent growth rate gains over the period 2025 to 2029. Commencing at 3.05% in 2025, growth builds up to 6.28% by 2029.

Angola's Influenza Vaccine market is anticipated to experience a stable growth rate of 4.97% by 2027, reflecting trends observed in the largest economy Egypt, followed by South Africa, Ethiopia, Algeria and Nigeria.

The influenza vaccine market in Angola is growing as public health initiatives and awareness campaigns emphasize the importance of vaccination. Government efforts to improve healthcare infrastructure and increase vaccine coverage are key drivers. The rising incidence of influenza and the need for preventive healthcare measures are also fueling market growth.
The growth of the Angola influenza vaccine market is driven by increasing awareness about the importance of vaccination and the rising incidence of influenza. Government initiatives to improve immunization coverage and the expansion of healthcare infrastructure also boost market growth. Additionally, advancements in vaccine development technologies and the introduction of new and improved influenza vaccines contribute to market expansion.
The influenza vaccine market in Angola struggles with challenges such as inadequate healthcare infrastructure and limited access to vaccines, especially in rural areas. There is also a significant lack of public awareness about the benefits of vaccination, leading to low uptake rates. Additionally, logistical challenges in vaccine storage and distribution, coupled with periodic shortages, impede the market`s effectiveness.
The government of Angola has established policies to ensure the availability and accessibility of influenza vaccines, including subsidies for vaccine production and distribution, partnerships with international health organizations, and public health campaigns to increase vaccination rates.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Angola Influenza Vaccine Market Overview |
3.1 Angola Country Macro Economic Indicators |
3.2 Angola Influenza Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Angola Influenza Vaccine Market - Industry Life Cycle |
3.4 Angola Influenza Vaccine Market - Porter's Five Forces |
3.5 Angola Influenza Vaccine Market Revenues & Volume Share, By Vaccine type, 2021 & 2031F |
3.6 Angola Influenza Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Angola Influenza Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Angola Influenza Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Angola Influenza Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Angola Influenza Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Angola |
4.2.2 Government initiatives to improve healthcare infrastructure and accessibility to vaccines |
4.2.3 Rising incidence of influenza cases in Angola |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas of Angola |
4.3.2 High cost associated with influenza vaccines |
4.3.3 Lack of trained healthcare professionals for vaccine administration |
5 Angola Influenza Vaccine Market Trends |
6 Angola Influenza Vaccine Market Segmentations |
6.1 Angola Influenza Vaccine Market, By Vaccine type |
6.1.1 Overview and Analysis |
6.1.2 Angola Influenza Vaccine Market Revenues & Volume, By Quadrivalent, 2021-2031F |
6.1.3 Angola Influenza Vaccine Market Revenues & Volume, By Trivalent, 2021-2031F |
6.2 Angola Influenza Vaccine Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Angola Influenza Vaccine Market Revenues & Volume, By Seasonal, 2021-2031F |
6.2.3 Angola Influenza Vaccine Market Revenues & Volume, By Pandemic, 2021-2031F |
6.3 Angola Influenza Vaccine Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Angola Influenza Vaccine Market Revenues & Volume, By Egg-based, 2021-2031F |
6.3.3 Angola Influenza Vaccine Market Revenues & Volume, By Cell-based, 2021-2031F |
6.4 Angola Influenza Vaccine Market, By Age Group |
6.4.1 Overview and Analysis |
6.4.2 Angola Influenza Vaccine Market Revenues & Volume, By Pediatric, 2021-2031F |
6.4.3 Angola Influenza Vaccine Market Revenues & Volume, By Adult, 2021-2031F |
6.5 Angola Influenza Vaccine Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Angola Influenza Vaccine Market Revenues & Volume, By Injection, 2021-2031F |
6.5.3 Angola Influenza Vaccine Market Revenues & Volume, By Nasal Spray, 2021-2031F |
7 Angola Influenza Vaccine Market Import-Export Trade Statistics |
7.1 Angola Influenza Vaccine Market Export to Major Countries |
7.2 Angola Influenza Vaccine Market Imports from Major Countries |
8 Angola Influenza Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage in Angola |
8.2 Number of government-funded vaccination programs implemented |
8.3 Rate of influenza cases reported in Angola |
8.4 Percentage of the population receiving annual influenza vaccination |
8.5 Number of healthcare facilities equipped to administer influenza vaccines |
9 Angola Influenza Vaccine Market - Opportunity Assessment |
9.1 Angola Influenza Vaccine Market Opportunity Assessment, By Vaccine type, 2021 & 2031F |
9.2 Angola Influenza Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Angola Influenza Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Angola Influenza Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.5 Angola Influenza Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Angola Influenza Vaccine Market - Competitive Landscape |
10.1 Angola Influenza Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Angola Influenza Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here